Schedule 13G ownership disclosure

Celldex Therapeutics Inc

COMMON STOCK · CUSIP: 15117B202

Event date: 2025-12-31

Filing-level shares
3,397,713.00
Percent of class
5.1%
  • STATE STREET CORPORATION

    Shares: 3,397,713.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000033
Form type
SCHEDULE 13G
Filer
Celldex Therapeutics, Inc.
CIK
CIK 744218
Filed
Feb 09, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub